Azilsartan trimethylethanolamine

Drug Profile

Azilsartan trimethylethanolamine

Alternative Names: Azilsartan choline; Choline azilsartan

Latest Information Update: 20 Jun 2016

Price : $50

At a glance

  • Originator Jiangsu Hansoh Pharmaceutical
  • Class Antihypertensives; Benzimidazoles; Ethanolamines; Oxadiazoles; Small molecules
  • Mechanism of Action Angiotensin type 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Hypertension

Most Recent Events

  • 11 Mar 2016 Phase-I development is ongoing in China
  • 30 Sep 2013 Phase-I clinical trials in Hypertension (in volunteers) in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top